Literature DB >> 7004043

The ketotic effects of glucocorticoid and growth hormone in man.

D S Schade, R P Eaton, G T Peake.   

Abstract

The ketotic effects of both glucocorticoid and growth hormone were assessed in normal man. Experimental protocols, previously shown to induce marked ketosis in diabetic man, were utilized to explore the metabolic effects of these two stress hormones in subjects with normal insulin secretory capacity. Glucocorticoid was administered orally as 1 mg of dexamethasone at 24 and 8 h prior to study. Growth hormone was administered subcutaneously at a dosage of 1 mg, 12 h prior to study. During the 90-min study of the ketotic activity of these hormones, plasma nonesterified fatty acids were acutely increased by heparin administration to support hepatic ketogenesis. This technique permitted an assessment of the ketotic activity of glucocorticoid and growth hormone independent of their lipolytic activity. The results of this study demonstrate that glucocorticoid may cause minimal hyperketonemia in spite of hyperinsulinemia in normal man. However, this effect is accompanied by a glucocorticoid-induced instability in basal ketone body and nonesterified fatty acid concentration. In contrast, no effect of growth hormone on plasma ketone body concentration or insulin levels was observed. These results in normal man contrast to the marked ketosis previously induced by these two stress hormones in diabetic man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004043     DOI: 10.1007/bf02580998

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  15 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Studies in fat metabolism. III. The effect of ACTH, of cortisone, and of other steroid compounds upon fasting-induced hyperketonemia and ketonuria.

Authors:  L W KINSELL; S MARGEN; G D MICHAELS; R REISS; R FRANTZ; J CARBONE; J LANGE; G LIEBERT
Journal:  J Clin Invest       Date:  1951-12       Impact factor: 14.808

3.  Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon.

Authors:  J McGarry; P H Wright; D W Foster
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  Glucocorticoid regulation of plasma ketone body concentration in insulin devicient man.

Authors:  D S Schade; R P Eaton; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1977-06       Impact factor: 5.958

5.  Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma.

Authors:  J W Ensinck; C Shepard; R J Dudl; R H Williams
Journal:  J Clin Endocrinol Metab       Date:  1972-09       Impact factor: 5.958

6.  Further characterisation of lipoprotein lipase and hepatic post-heparin lipase from rat plasma.

Authors:  C J Fielding
Journal:  Biochim Biophys Acta       Date:  1972-12-08

7.  Prospective study of 352 young patients with chemical diabetes.

Authors:  J B O'Sullivan; C M Mahan
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

8.  Metabolic response to human growth hormone during prolonged starvation.

Authors:  P Felig; E B Marliss; G F Cahill
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

9.  Semi-automated micro-scale extraction apparatus for assay of free fatty acids in plasma.

Authors:  D S Schade; G Burke; R P Eaton; J DeMoss
Journal:  Clin Chem       Date:  1978-09       Impact factor: 8.327

10.  Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man.

Authors:  R S Sherwin; R G Hendler; P Felig
Journal:  Diabetes       Date:  1976-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.